source
- As H-1B visa changes keep coming, biopharmas adjust hiring approachThe $100,000 H-1B visa fee has significantly affected who biopharma companies hire, according to two experts. It’s not the only program adjustment affecting foreign-born job seekers’ odds of workin…BioSpace · 1h ago↗ source
- Critical decisions that spurred these 40 Under 40 winners to successSecuring financing that allowed an exit from academia, leaving ecology and evolutionary biology for biomedical engineering and shifting from business development to entrepreneurship are among key t…BioSpace · 1h ago↗ source
- ESMO 2026: Merck’s Kelun-partnered ADC hits the ‘Goldilocks zone,’ VP saysAt the European Society for Medical Oncology meeting this weekend, Merck will showcase three late-stage trials of its Kelun-Biotech–partnered TROP2-directed antibody sac-TMT that VP of Chemistry Al…